Page last updated: 2024-11-05

veratraldehyde

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Veratraldehyde, also known as 3,4-dimethoxybenzaldehyde, is a naturally occurring organic compound found in various plants, including vanilla. It is a colorless to pale yellow liquid with a sweet, aromatic odor. Veratraldehyde is synthesized commercially through the methylation of vanillin, a process involving the reaction of vanillin with dimethyl sulfate.

Veratraldehyde exhibits various biological activities, including antioxidant, antimicrobial, and anti-inflammatory properties. It has been studied for its potential therapeutic effects in various diseases, including cancer, diabetes, and neurodegenerative disorders. Its antioxidant activity is attributed to its ability to scavenge free radicals, while its antimicrobial activity is due to its ability to inhibit the growth of bacteria and fungi.

Veratraldehyde is used as a flavoring agent in the food industry and as an intermediate in the synthesis of various pharmaceuticals and agrochemicals. Its importance lies in its versatility as a building block for various organic compounds and its potential therapeutic applications. The study of veratraldehyde is driven by its diverse biological activities and potential applications in various fields.
'

Cross-References

ID SourceID
PubMed CID8419
CHEMBL ID1088937
CHEBI ID17098
SCHEMBL ID25202
MeSH IDM0389746

Synonyms (92)

Synonym
wln: vhr co1 do1
veratral
nsc-8500
veratryl aldehyde
4-o-methylvanillin
p-veratric aldehyde
methylvanillin
protocatechuic aldehyde dimethyl ether
vanillin methyl ether
nsc8500
protocatechualdehyde dimethyl ether
3,4-dimethoxybenzenecarbonal
benzaldehyde,4-dimethoxy-
CHEBI:17098 ,
nsc-24521
nsc24521
AH-034/32845024
inchi=1/c9h10o3/c1-11-8-4-3-7(6-10)5-9(8)12-2/h3-6h,1-2h
3,4-dimethoxy-benzaldehyde
benzaldehyde, 3,4-dimethoxy-
NCGC00091642-01
protocatechuecaldehyde dimethyl ether
nsc 24521
einecs 204-373-2
brn 0473899
fema no. 3109
ai3-08099
ccris 6285
veratrum aldehyde
veratraldehyde ,
3,4-dimethoxybenzaldehyde
C02201
120-14-9
veratric aldehyde
veratraldehyde, >=98%, fg
3,4-dimethoxybenzaldehyde, 99%
NCGC00091642-02
STK188425
D0507
BMSE010220
FT-0667232
CHEMBL1088937
AKOS000118989
NCGC00091642-03
3,4-dimethoxy benzaldehyde
tox21_303074
NCGC00257217-01
cas-120-14-9
dtxsid7026285 ,
dtxcid406285
tox21_201566
NCGC00259115-01
BBL010373
S3214
methyl vanillin
fema 3109
ui88p68jzd ,
unii-ui88p68jzd
FT-0600118
AM20050100
veratraldehyde [fhfi]
veratraldehyde [fcc]
verapamil hydrochloride impurity g [ep impurity]
veratraldehyde [mi]
SCHEMBL25202
4,3-dimethoxybenzaldehyde
3,4-dimethoxybenzaidehyde
3,4dimethoxybenzaldehyde
4,5-dimethoxybenzaldehyde
3,4 dimethoxybenzaldehyde
3,4-dimethoxybenzaldeyde
3, 4-dimethoxybenzaldehyde
AC-10201
AC-34441
W-108485
mfcd00003363
F2190-0618
veratrumaldehyde
benzaldehyde, 3,4-dimethoxy-veratraldehyde
SY004136
CS-W019906
Q414395
AS-11996
EN300-16145
veratraldehyde (3,4-dimethoxybenzaldehyde)
HY-N1096
benzaldehyde, 3-methoxy-4-(methoxy-d3)-
veratrumald
ratryl aldehyde
dimethoxy-benzaldehyde-o-methylvanillin
3,4-dimethoxy
Z53837671
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
antifungal agentAn antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
benzaldehydesAny arenecarbaldehyde that consists of a formyl substituted benzene ring and its substituted derivatives thereof.
dimethoxybenzeneAny methoxybenzene that consists of a benzene skeleton substituted with two methoxy groups and its derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (17)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency61.75280.006038.004119,952.5996AID1159521
SMAD family member 2Homo sapiens (human)Potency31.23230.173734.304761.8120AID1346859
SMAD family member 3Homo sapiens (human)Potency31.23230.173734.304761.8120AID1346859
GLI family zinc finger 3Homo sapiens (human)Potency17.78520.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency34.72610.000221.22318,912.5098AID1259381
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency11.22020.011212.4002100.0000AID1030
thyroid stimulating hormone receptorHomo sapiens (human)Potency1.99530.001318.074339.8107AID926; AID938
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency77.74210.000657.913322,387.1992AID1259377
progesterone receptorHomo sapiens (human)Potency61.75280.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency37.80660.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency55.53980.000817.505159.3239AID1159527
pregnane X nuclear receptorHomo sapiens (human)Potency61.75280.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency40.60110.000229.305416,493.5996AID1259244; AID743069; AID743075; AID743079
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency13.80220.023723.228263.5986AID743222
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency49.49990.057821.109761.2679AID1159526
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency77.74210.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency77.74210.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID1226091Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBV DNA replication by real-time fluorescence quantitative PCR analysis2015European journal of medicinal chemistry, May-05, Volume: 95Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents.
AID1113014Covalent binding to Meloidogyne javanica (root-knot nematode) collagen 3 assessed as compound-protein adduct formation at 1 mM by HPLC-ESI-MS analysis2013Journal of agricultural and food chemistry, Feb-27, Volume: 61, Issue:8
Potent nematicidal activity of phthalaldehyde, salicylaldehyde, and cinnamic aldehyde against Meloidogyne incognita.
AID1113012Covalent binding to Meloidogyne javanica (root-knot nematode) collagen 3 assessed as compound-protein adduct formation at 5 mM by HPLC-ESI-MS analysis2013Journal of agricultural and food chemistry, Feb-27, Volume: 61, Issue:8
Potent nematicidal activity of phthalaldehyde, salicylaldehyde, and cinnamic aldehyde against Meloidogyne incognita.
AID475504Binding affinity to amyloid beta (1 to 42) fibrils by change in fluorescence at 100 uM after 10 mins2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.
AID475505Binding affinity to amyloid beta (1 to 42) oligomers by change in fluorescence at 100 uM after 10 mins2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.
AID1226092Selectivity index, ratio of CC50 for human HepG2.2.15 cells to IC50 for Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBV DNA replication2015European journal of medicinal chemistry, May-05, Volume: 95Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents.
AID1113018Nematicidal activity against second-stage juveniles of Meloidogyne incognita (root-knot nematode) after 1 hr by inverted microscopic analysis2013Journal of agricultural and food chemistry, Feb-27, Volume: 61, Issue:8
Potent nematicidal activity of phthalaldehyde, salicylaldehyde, and cinnamic aldehyde against Meloidogyne incognita.
AID1226086Cytotoxicity against human HepG2.2.15 cells assessed as cell death after 9 days by MTT assay2015European journal of medicinal chemistry, May-05, Volume: 95Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents.
AID1113013Covalent binding to Meloidogyne javanica (root-knot nematode) collagen 3 assessed as compound-protein adduct formation at 15 mM by HPLC-ESI-MS analysis2013Journal of agricultural and food chemistry, Feb-27, Volume: 61, Issue:8
Potent nematicidal activity of phthalaldehyde, salicylaldehyde, and cinnamic aldehyde against Meloidogyne incognita.
AID1113017Nematicidal activity against second-stage juveniles of Meloidogyne incognita (root-knot nematode) after 1 day by inverted microscopic analysis2013Journal of agricultural and food chemistry, Feb-27, Volume: 61, Issue:8
Potent nematicidal activity of phthalaldehyde, salicylaldehyde, and cinnamic aldehyde against Meloidogyne incognita.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (15.38)18.7374
1990's0 (0.00)18.2507
2000's10 (38.46)29.6817
2010's11 (42.31)24.3611
2020's1 (3.85)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 44.27

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index44.27 (24.57)
Research Supply Index3.33 (2.92)
Research Growth Index5.35 (4.65)
Search Engine Demand Index62.36 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (44.27)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other27 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]